Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
13.89
+0.45 (3.35%)
At close: Mar 9, 2026, 4:00 PM EDT
14.01
+0.12 (0.86%)
Pre-market: Mar 10, 2026, 5:39 AM EDT
Intellia Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 155.46 | 189.18 | 226.75 | 523.51 | 123.41 | Upgrade
|
| Short-Term Investments | 294.42 | 412.33 | 685.48 | 669.12 | 625.28 | Upgrade
|
| Cash & Short-Term Investments | 449.88 | 601.52 | 912.22 | 1,193 | 748.69 | Upgrade
|
| Cash Growth | -25.21% | -34.06% | -23.51% | 59.29% | 25.33% | Upgrade
|
| Receivables | 9.47 | 8.52 | 36.46 | 3.77 | 2.03 | Upgrade
|
| Prepaid Expenses | 68.36 | 29.83 | 47.55 | 20.41 | 18.58 | Upgrade
|
| Other Current Assets | - | - | 2.1 | - | - | Upgrade
|
| Total Current Assets | 527.71 | 639.86 | 998.33 | 1,217 | 769.3 | Upgrade
|
| Property, Plant & Equipment | 123.63 | 246.67 | 148.14 | 161 | 100.11 | Upgrade
|
| Long-Term Investments | 177.71 | 287.09 | 136.39 | 126.59 | 420.29 | Upgrade
|
| Other Long-Term Assets | 13.08 | 17.39 | 18.12 | 15.73 | 4.76 | Upgrade
|
| Total Assets | 842.13 | 1,191 | 1,301 | 1,520 | 1,294 | Upgrade
|
| Accounts Payable | 20.25 | 14.59 | 7.45 | 5.15 | 9.65 | Upgrade
|
| Accrued Expenses | 49.86 | 55.36 | 60.13 | 60.88 | 43.31 | Upgrade
|
| Current Portion of Leases | 26.48 | 20.25 | 18.6 | 16.69 | 9.11 | Upgrade
|
| Current Unearned Revenue | 7.29 | 20.66 | 22.14 | 43.84 | 63.76 | Upgrade
|
| Other Current Liabilities | - | - | 6.89 | - | - | Upgrade
|
| Total Current Liabilities | 103.88 | 110.85 | 115.21 | 126.55 | 125.83 | Upgrade
|
| Long-Term Leases | 66.85 | 189.95 | 96.75 | 114.02 | 64.91 | Upgrade
|
| Long-Term Unearned Revenue | - | 18.26 | 38.85 | 19.93 | 63.48 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 24.03 | - | Upgrade
|
| Total Liabilities | 170.73 | 319.06 | 250.81 | 284.53 | 254.22 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 3,260 | 3,049 | 2,711 | 2,420 | 1,746 | Upgrade
|
| Retained Earnings | -2,590 | -2,177 | -1,658 | -1,177 | -703 | Upgrade
|
| Comprehensive Income & Other | 1.03 | 0.61 | -2.26 | -7.46 | -2.63 | Upgrade
|
| Total Common Equity | 671.39 | 871.96 | 1,050 | 1,236 | 1,040 | Upgrade
|
| Shareholders' Equity | 671.39 | 871.96 | 1,050 | 1,236 | 1,040 | Upgrade
|
| Total Liabilities & Equity | 842.13 | 1,191 | 1,301 | 1,520 | 1,294 | Upgrade
|
| Total Debt | 93.33 | 210.2 | 115.35 | 130.7 | 74.02 | Upgrade
|
| Net Cash (Debt) | 511.81 | 651.53 | 896.74 | 1,131 | 1,012 | Upgrade
|
| Net Cash Growth | -21.45% | -27.34% | -20.73% | 11.78% | 81.34% | Upgrade
|
| Net Cash Per Share | 4.72 | 6.59 | 10.10 | 14.70 | 14.28 | Upgrade
|
| Filing Date Shares Outstanding | 118.13 | 103.52 | 96.11 | 88.02 | 74.67 | Upgrade
|
| Total Common Shares Outstanding | 116.32 | 102.03 | 93 | 87.1 | 74.49 | Upgrade
|
| Working Capital | 423.83 | 529.01 | 883.12 | 1,090 | 643.47 | Upgrade
|
| Book Value Per Share | 5.77 | 8.55 | 11.29 | 14.19 | 13.97 | Upgrade
|
| Tangible Book Value | 671.39 | 871.96 | 1,050 | 1,236 | 1,040 | Upgrade
|
| Tangible Book Value Per Share | 5.77 | 8.55 | 11.29 | 14.19 | 13.97 | Upgrade
|
| Machinery | 71.16 | 71.97 | 67.59 | 56.33 | 43.34 | Upgrade
|
| Leasehold Improvements | 3.2 | 3.2 | 3.13 | 3.07 | 2.19 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.